AROC Archrock, Inc. Insider Trading

SVP Ingersoll Jason sold 33,000 AROC shares at $38.19; stock up 6.4% in 30d, 18.1% in 90d post-transaction, well-timed per cross-ticker track record.

On 2026-05-18, Jason Ingersoll, senior vice president of Archrock, Inc., sold 33,000 shares at $38.19, reducing his holdings from 310,454 to 277,454 shares (a 10.6% reduction). His cross-ticker track record shows a 100.00% well-timed rate on prior sells—a binary metric indicating he has previously exited before declines. However, in the 90 days following this specific AROC sale, the stock rose 18.1%, suggesting this particular trade diverged from his prior pattern; the stock did not fall as his historical track record might have predicted. This context—strong recent momentum (+6.4% in 30d, +18.1% in 90d) combined with a prior pattern of exiting before weakness—warrants observation of whether his exit, despite the subsequent rally, reflects a longer-term reassessment of the position or a methodological shift in his transaction approach.

Then-CFO Aron Doug S sold 35,000 shares of AROC at $38.30 on 2026-05-18 for $1,340,500.00

Aron Doug S, who was then-CFO, sold 35,000 shares (8.9% of his pre-transaction holdings) at $38.30, reducing his position from 394,337 to 359,337 shares. The stock is currently trading at $38.62, within 3.7% of its 52-week high of $40.12, and has gained 18.1% over 90 days. His prior sales at AROC (on 2026-03-30 and 2026-03-27) saw positive 90-day returns of 7.7% and 5.1% respectively, indicating he did not sell ahead of subsequent declines at this ticker. The company's fundamentals show strong momentum with annual revenue growth of +28.7%, quarterly net income of $73.8M, and a P/E of 20.76.

CFO-level executive sold 90,000 AROC shares for $3.3M; stock up 18.1% in 90 days since sale

Aron Doug S, who was CFO at the time, sold 90,000 shares of Archrock (AROC) at $36.74 on 2026-05-14, reducing his holdings by 18.6% to 394,337 shares. At his prior two sales at this ticker (2026-03-30 and 2026-03-27), the stock rose 7.7% and 5.1% respectively in the 90 days following those sales, indicating neither transaction was well-timed on a forward-looking basis. Current price of $38.62 reflects an 18.1% gain over 90 days since this latest sale, continuing the pattern of post-sale price appreciation rather than decline. The company is growing rapidly (28.7% annual revenue growth) with a P/E of 20.76 and net income of $73.8M, providing fundamental backdrop for sustained upward price momentum that this insider's sale preceded rather than anticipated.

CFO Doug Aron sold 169,550 shares of AROC for $5,954,333.00 across two transactions (March 27–30)

Doug Aron, Senior Vice President and CFO of Archrock, executed two separate sales totaling 169,550 shares for $5,954,333.00, reducing his holdings by 25.9% from 653,887 shares to 484,337 shares. The sales occurred on March 27 and March 30 at prices of $35.61 and $34.76 respectively, near the stock's current level of $34.80 and within its 52-week range of $21.00–$37.04. Given Archrock's strong recent fundamentals—revenue growth of 28.7% year-over-year, net income of $71,248,000.00, and a P/E of 14.68—this material reduction in the CFO's stake merits monitoring. The filing does not indicate a 10b5-1 trading plan FLAG, so the discretionary nature and timing of the sales are relevant to interpretation; however, without visibility into his prior transaction history or scheduled equity events, the specific driver of the sales cannot be definitively characterized from the available data alone.

SVP Eric Thode sold 40,740 shares of AROC at $25.10 on 2025-11-10, reducing holdings by 18.1%.

Eric Thode, Senior Vice President of Archrock, sold 40,740 shares at $25.10, representing an 18.1% reduction of his pre-transaction holdings from 224,956 shares to 184,216 shares. The sale occurred above the current market price of $24.99, though the transaction price of $25.10 remains 17.6% below the 52-week high of $30.34. The company's fundamentals remain solid with annual revenue growth of +16.9%, a P/E of 16.55, and recent quarterly net income of $71.2M on revenue of $382.4M. Without scheduled trading plan information, the magnitude of the holding reduction and the timing relative to price action warrant monitoring for potential shifts in executive positioning.

Director Rebrook buys 5,000 AROC shares at $23.94; 3rd consecutive buy in 4 days as stock trades -15.7% from 52-week high

Jason C Rebrook, a director at Archrock, Inc., purchased 5,000 shares at $23.94 on 2025-09-22, increasing his holdings to 79.5K shares. This is his third consecutive buy at AROC over a 4-day window (2025-09-18, 2025-09-19, 2025-09-22), representing cumulative discretionary buying activity. The stock is currently 15.7% below its 52-week high of $30.34, and the company's fundamentals remain solid with quarterly revenue of $383.2M, net income of $63.4M, and annual revenue growth of 16.9%. The clustering of three buys within 4 days at depressed valuations relative to the 52-week range, coupled with the company's positive earnings and growth trajectory, suggests deliberate accumulation during a pullback period. Investors should monitor whether this pattern continues and track the stock's recovery relative to the 52-week high.

Director Rebrook Jason C purchases 10,000 shares of AROC at $24.16; position increases to 74,511 shares.

Jason C. Rebrook, a Director, purchased 10,000 shares at $24.16 on 2025-09-19, expanding his holdings by +15.5% to 74,511 shares post-transaction. The stock currently trades at $24.48, representing a -19.3% decline from its 52-week high of $30.34. His cross-ticker track record shows only 2 prior open-market buys with no measurable 90-day outcomes, providing limited historical context for assessing timing precision. The company exhibits solid fundamentals with $383.2M in latest-quarter revenue and +16.9% annual revenue growth, yet the P/E of 18.55 and recent -2.9% 30-day price decline warrant monitoring against the stock's broader downtrend from its 52-week peak.

Director Rebrook buys 10,000 shares at $24.17; holdings rise 18.3% to 64,511 shares in strong AROC fundamentals

Rebrook Jason C, a Director, purchased 10,000 shares at $24.17 on 2025-09-18, expanding his position by 18.3% from 54,511 to 64,511 shares and deploying $241,670.00 in capital. The purchase occurs at a price 20.6% below the 52-week high of $30.34 and within the company's strong operational context: latest quarter revenue of $383,152,000.00 with net income of $63,420,000.00, annual revenue growth of 16.9%, and a P/E of 18.26. The current market price of $24.10 sits only 0.07 below the transaction price, and the 30-day and 90-day price changes are modest at -2.1% and -3.4% respectively, suggesting modest recent momentum shifts. This represents his first documented discretionary open-market purchase at AROC and his second cumulative buy across all tickers, marking a meaningful capital commitment to the company at a point in the valuation cycle where the stock is trading well below its 52-week peak.

SVP Jason Ingersoll sold 42,036 shares of AROC at $24.49; retains 275,911 shares post-sale

Jason Ingersoll, a senior vice president at Archrock, sold 42,036 shares at $24.49 on 2025-05-09, reducing his stake by 13.2% to 275,911 shares, for a total transaction value of $1,029,377.57. The sale occurred when the stock was trading at $24.49, roughly 19.2% below the current price of $25.32 and 16.6% below the 52-week high of $30.34. While Archrock shows solid fundamentals—16.9% annual revenue growth, a market cap of $4,476,808,488.24, and a P/E of 22.02—the sale represents a meaningful reduction in a senior executive's holdings at a price below both current and recent peak valuations. The transaction merits review of whether it reflects a scheduled reduction plan or discretionary decision-making by the executive.